Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Other Comprehensive Loss (Unaudited)

v3.19.3
Condensed Consolidated Statements of Operations and Other Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Income Statement [Abstract]        
Net sales $ 2,766 $ 2,439 $ 6,735 $ 9,033
Cost of sales 1,932 1,683 5,120 5,593
Gross profit 834 756 1,615 3,440
Operating expenses:        
Sales and marketing 302 395 910 802
Administration 936 1,129 3,232 3,547
Research and development 57 144 246 319
Total operating expenses 1,295 1,668 4,388 4,668
Loss from operations (461) (912) (2,773) (1,228)
Interest income, net 33 15 94 115
Loss from continuing operations (428) (897) (2,679) (1,113)
Discontinued operations:        
Loss on sale of discontinued operations, net of taxes (160) (160)
Loss from discontinued operations (160) (160)
Net (loss) (428) (1,057) (2,679) (1,273)
Other comprehensive loss:        
Unrealized gain (loss) on marketable debt securities (5) 28 18 54
Total comprehensive loss $ (433) $ (1,029) $ (2,661) $ (1,219)
Basic loss per share:        
Loss from continuing operations $ (0.04) $ (0.08) $ (0.23) $ (0.10)
Loss from discontinued operations (0.01) (0.01)
Net loss (0.04) (0.09) (0.23) (0.11)
Diluted loss per share:        
Loss from continuing operations (0.04) (0.08) (0.23) (0.10)
Loss from discontinued operations (0.01) (0.01)
Net loss (0.04) (0.09) (0.23) (0.11)
Weighted average common shares outstanding:        
Basic and diluted $ 11,565,000 $ 11,541,000 $ 11,561,000 $ 11,344,000